Executive Summary of the 2020 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines.

Autor: Gonzalez-Santos LE; Division of Hypertension, Department of Medicine, University of the Philippines College of Medicine-Philippine General Hospital., Oliva R; Division of Hypertension, Department of Medicine, University of the Philippines College of Medicine-Philippine General Hospital., Jimeno C; Department of Pharmacology and Toxicology, University of the Philippines College of Medicine., Gonzales E; Department of Internal Medicine, Batangas Medical Center, Philippines., Margarita Balabagno M; Department of Cardiology, Perpetual Help DALTA Medical Center-Las Pinas City, Philippines., Ona D; Division of Hypertension, Department of Medicine, University of the Philippines College of Medicine-Philippine General Hospital., Cinco JE; Department of Cardiology, The Medical City, Pasig City, Philippines., Baston A; Department of Internal Medicine, Emilio Aguinaldo College Medical Center-Cavite, Philippines., Caole-Ang I; College of Medicine, Pamantasan ng Lungsod ng Maynila, Philippines., Fojas M; Department of Biochemistry and Molecular Biology, University of the Philippines College of Medicine., Hernandez RF; Department of Pediatrics, De La Salle University Medical Center and De La Salle Health Science Institute, College of Medicine, Dasmariñas, Cavite, Philippines., Macrohon-Valdez MC; Institute of Neurosciences, St. Luke's Medical Center, Global City, Taguig, Philippines., Theresa Rosqueta M; Philippine Heart Center., Punzalan FE; Division of Cardiovascular Medicine, Department of Medicine, University of the Philippines College of Medicine-Philippine General Hospital., Llanes EJ; Division of Cardiovascular Medicine, Department of Medicine, University of the Philippines College of Medicine-Philippine General Hospital.

Publikováno v: Journal of the ASEAN Federation of Endocrine Societies [J ASEAN Fed Endocr Soc] 2021; Vol. 36 (1), pp. 5-11. Date of Electronic Publication: 2021 Mar 10.

Pre-Operative Sildenafil for Patients With Pulmonary Hypertension Undergoing Mitral Valve Surgery: A Systematic Review and Meta-Analysis.

Autor: Villanueva DLE; Division of Cardiovascular Medicine, University of the Philippines, Philippine General Hospital, Manila 1000, Philippines., Agustin RD; Division of Cardiovascular Medicine, University of the Philippines, Philippine General Hospital, Manila 1000, Philippines., Llanes EJ; Division of Cardiovascular Medicine, University of the Philippines, Philippine General Hospital, Manila 1000, Philippines.

Publikováno v: Cardiology research [Cardiol Res] 2019 Dec; Vol. 10 (6), pp. 369-377. Date of Electronic Publication: 2019 Nov 24.

A community-based validation study of the short-form 36 version 2 Philippines (Tagalog) in two cities in the Philippines.

Autor: Castillo-Carandang NT; Department of Clinical Epidemiology, College of Medicine, and Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines (U.P.) Manila, Manila, Philippines ; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines., Sison OT; Department of Clinical Epidemiology, College of Medicine, and Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines (U.P.) Manila, Manila, Philippines ; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines., Grefal ML; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines., Sy RG; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines ; Cardinal Santos Medical Center, San Juan City, Metro Manila, Philippines  , Alix OC; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines., Llanes EJ; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines., Reganit PF; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines., Gumatay AW; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines., Punzalan FE; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines., Velandria FV; LIFEcourse study in CARdiovascular disease Epidemiology (LIFECARE) Philippines Study Group, Lipid Research Unit, U.P.-Philippine General Hospital, U.P. Manila, Manila, Philippines., Tai ES; Department of Medicine, Yong Loo Lin School of Medicine, National University Health System, Singapore, Singapore., Wee HL; Department of Pharmacy, National University of Singapore and Department of Rheumatology & Immunology, Singapore General Hospital, Singapore, Singapore.

Publikováno v: PloS one [PLoS One] 2013 Dec 26; Vol. 8 (12), pp. e83794. Date of Electronic Publication: 2013 Dec 26 (Print Publication: 2013).